Circulating tumor DNA integrating tissue clonality detects minimal residual disease in resectable non-small-cell lung cancer

Siwei Wang, Ming Li, Jingyuan Zhang, Xing Peng, Min Wu, Fancheng Meng, Feng Jiang, Jie Wang, Hua Bao, Jianfeng Huang, Binhui Ren, Mingfeng Yu, Ninglei Qiu, Houhuai Li, Fangliang Yuan, Zhi Zhang, Hui Jia, Xinxin Lü, Shuai Zhang, Xiaojun Wang, Youtao Xu, Wenjia Xia, Tongyan Liu, Weizhang Xu, Xinyu Xu, Mengting Sun, Xue Wu, Yang Shao, Qianghu Wang, Juncheng Dai, Mantang Qiu, Jinke Wang, Qin Zhang, Lin Xu, Hongbing Shen, Rong YinJournal of Hematology & Oncology 2022 · DOI · OpenAlex

Abstract

Longitudinal ctDNA surveillance integrating clonality information may stratify high-risk patients with disease recurrence and infer the evolutionary origin of ctDNA mutations.
BibTeX
@article{wang2022circulating,
  author = {Siwei Wang and Ming Li and Jingyuan Zhang and Xing Peng and Min Wu and Fancheng Meng and Feng Jiang and Jie Wang and Hua Bao and Jianfeng Huang and Binhui Ren and Mingfeng Yu and Ninglei Qiu and Houhuai Li and Fangliang Yuan and Zhi Zhang and Hui Jia and Xinxin Lü and Shuai Zhang and Xiaojun Wang and Youtao Xu and Wenjia Xia and Tongyan Liu and Weizhang Xu and Xinyu Xu and Mengting Sun and Xue Wu and Yang Shao and Qianghu Wang and Juncheng Dai and Mantang Qiu and Jinke Wang and Qin Zhang and Lin Xu and Hongbing Shen and Rong Yin},
  title = {{Circulating tumor DNA integrating tissue clonality detects minimal residual disease in resectable non-small-cell lung cancer}},
  journal = {Journal of Hematology \& Oncology},
  year = {2022},
  doi = {10.1186/s13045-022-01355-8},
}

Loading related content...

Figure